期刊文献+

二甲双胍联合TC方案治疗晚期卵巢癌的临床观察 被引量:2

Clinical Observations on Metformin United TC Scheme in Advanced Ovarian Cancer
下载PDF
导出
摘要 目的分析比较二甲双胍联合TC方案和单纯TC方案在伴有糖尿病的中老年晚期卵巢癌患者术后辅助化疗中的临床疗效。方法 60例伴有糖尿病的中老年晚期卵巢癌患者,均用胰岛素控制血糖良好,随机分为治疗组和对照组,每组30例,治疗组采用二甲双胍联合TC方案治疗,对照组采用TC方案治疗。两组患者治疗均以21d为1个周期。至少完成2周期化疗的患者进行疗效、毒副反应评价。结果治疗组的临床疗效优于对照组,治疗组有效28例(93.3%);对照组有效19例(63.3%)。两组比较,差异具有统计学意义(P<0.05)。两组的副反应相比,差异无统计学意义(P>0.05)。结论采用二甲双胍联合TC方案治疗伴糖尿病的中老年人晚期卵巢癌的临床疗效确切,不良反应并未明显增加,值得在临床推广应用。 Objective To compare the clinical effect in assistant chemotherapy of metformin united TC scheme and alone TC scheme in elderly patients suffering from advanced ovarian cancer and diabetes.Methods Sixty elderly patients suffering from advanced ovarian cancer and diabetes,all with insulin to control blood sugar well,random-ly were divided into treatment group and control group.The treatment group were treated with metformin united TC scheme,the control group with TC scheme only.Twenty-one days as a treatment cycle.the efficacy and side effects in pa-tients at least two cycles of chemotherapy were evaluated.Results The clinical efficacy of the treatment group is better than the control group.There are twenty-eight cases of effective in the treatment group and the effective rate is 93.3%. There are nineteen cases of effective in the control group and the effective rate is 63 .3%,the effective rate were statisti-cally significant(P〈0.05).Theside effects were not statistically significant(P〉0.05).Conclusion The clinical effi-cacy of treatment with metformin united TC program in elderly patients suffering from advanced ovarian cancer and diabe-tes is exact and the adverse effects did not significantly increase.It is worth promoting to apply in clinical practice.
出处 《潍坊医学院学报》 2015年第6期412-414,共3页 Acta Academiae Medicinae Weifang
关键词 二甲双胍 紫杉醇 卡铂 卵巢肿瘤 糖尿病 Metformin Paclitaxel Carboplatin Ovarian cancer Diabetes
  • 相关文献

参考文献10

二级参考文献56

  • 1郭瑞霞,魏丽惠.磷脂酰肌醇3激酶/蛋白激酶B信号传导通路与妇科恶性肿瘤关系的研究进展[J].中华妇产科杂志,2005,40(5):358-360. 被引量:22
  • 2Murakami D,Tsujitani S,Osaki T,et al.Expression of phosphorylated Akt (pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy[J].Gastric Cancer,2007,10(1):45-51. 被引量:1
  • 3Singh B,Reddy PG,Goberdhan A,et al.P53 regulates cell sunial by inhibiting PIK3CA in squamous cell carcinomas[J].Genes Dev,2002,16(8):984-993. 被引量:1
  • 4K im VN.Small RNA s classification,biogenesis and function[J].Mol Cells,2005,9(1):1-15. 被引量:1
  • 5Tomari Y,Zamore PD.Perspective machines for RNAi[J].Genes Dev,2005,19(5):517-529. 被引量:1
  • 6Paddison PJ,Candy AA,Bemstein E,et al.Short hairp inRNA s (shRNAs) induce sequence specific silencing in m amm alian cells[J].Genes Dev,2002,16:948-958. 被引量:1
  • 7Pfisterer J,Ledermann JA.Management of platinum-sensitive recurrent ovarian cancer[J].Semin Oncol,2006,33(6):6-12. 被引量:1
  • 8Jemal A,Siegel R.Cancer statistics,2007[J].CA Cancer J Clin,2007,57(1):43-66. 被引量:1
  • 9Micha JP,Goldstein BH.Pilot study of outpatient paclitaxel,carboplatin and gemcitabine for advanced stage epithelial ovarian,peritoneal,and fallopian tube cancer[J].Gynecol Oncol,2004,94:719-724. 被引量:1
  • 10Tewari D,Monk BJ.Gemcitabine and cisplatin chemotherapy is an active combination in the treatment of platinum-resistant ovarian and peritoneal carcinoma[J].Invest New Drugs,2004,22(4):475-480. 被引量:1

共引文献14

同被引文献9

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部